Login
Subscribe
Decoy Cells Trick SARS-CoV-2, Reduce Cytokines In Vitro
Decoy Cells Trick SARS-CoV-2, Reduce Cytokines In Vitro
Genetically engineered cells that overproduce ACE2, the receptor the novel coronavirus uses to enter cells, neutralize infection in vitro and mop up inflammatory cytokines in mice.
Genetically engineered cells that overproduce ACE2, the receptor the novel coronavirus uses to enter cells, neutralize infection in vitro and mop up inflammatory cytokines in mice.
cytokines, cell & molecular biology
Is a Bradykinin Storm Brewing in COVID-19?
Alakananda Dasgupta | Aug 26, 2020 | 5 min read
Excess of the inflammatory molecule bradykinin may explain the fluid build-up in the lungs of patients with coronavirus infections. Clinical trials of inhibitors are putting this hypothesis to the test.
Could Statins Reduce the Severity of COVID-19?
Ashley Yeager | Jun 12, 2020 | 7 min read
The cholesterol-lowering drugs quell inflammation and reverse endothelial tissue damage, hints that they might curb the body’s excessive immune response to SARS-CoV-2 infection.
Image of the Day: Resilient Lung Cells
Nicoletta Lanese | Aug 1, 2019 | 1 min read
A specific type of lung cell withstands flu infection by doubling down on DNA repair.
Wiping Out Gut Bugs Stops Obesity
Kerry Grens | Nov 16, 2015 | 1 min read
In mice lacking intestinal microbiota, white fat turns brown and obesity is prevented.